AGNES Microneedling Lawsuit

AGNES RF microneedling uses specialized needles and radiofrequency energy to heat tissue beneath the skin. Although practitioners offer the procedure for facial contouring and other cosmetic concerns, complications may include burns, scarring, unintended facial fat loss, and nerve injuries.

  • Best Law Firms 2027, U.S. News & World Report and Best Lawyers
  • Best Law Firms 2026, U.S. News & World Report and Best Lawyers
  • Best Lawyers Lawyer of the Year 2026, C.L. Mike Schmidt
  • 10 Best Attorney Client Satisfaction 2026, American Institute of Personal Injury Attorneys
  • Best Lawyers Lawyer of the Year 2026
  • Super Lawyers 2026
  • Best Lawyers Lawyer of the Year 2025, C.L. Mike Schmidt
  • 10 Best Attorney Client Satisfaction 2021, American Institute of Personal Injury Attorneys
  • American Bar Association
  • American Association for Justice Leaders Forum
  • American College of Trial Lawyers
  • American Board of Trial Advocates Diplomate
  • Martindale-Hubbell AV Preeminent
  • Martindale-Hubbell Peer Review Rated
  • International Society of Barristers
  • International Academy of Trial Lawyers
  • Best of the Best Top 10 Attorneys
  • Best Law Firms 2022, U.S. News & World Report and Best Lawyers
Table of contents
  1. Latest News
  2. November 2026
  3. September 2026
  4. October 2025
  5. September 2025
  6. October 2019
  7. What Is AGNES RF Microneedling?
  8. What’s the Problem With AGNES Microneedling?
  9. What Injuries Can RF Microneedling Cause?
  10. Can AGNES Microneedling Cause Facial Fat Loss?
  11. Can AGNES Microneedling Cause Permanent Scarring?
  12. Is AGNES Microneedling FDA Approved?
  13. Is There an AGNES RF Microneedling Recall?
  14. Could an AGNES Microneedling Injury Lead to a Lawsuit?
  15. Who Could Be Liable for an AGNES Treatment Injury?
  16. Who May Be Affected by AGNES Microneedling Complications?
  17. Do I Qualify for an AGNES Microneedling Lawsuit?
  18. What Evidence Is Important in an AGNES Microneedling Case?
  19. How Can Patients Report RF Microneedling Injuries?
  20. What Compensation May Be Available?
  21. Speak With an AGNES Microneedling Lawyer
  22. How Does an AGNES Microneedling Lawsuit Work?
  23. Frequently Asked Questions
  24. What is the AGNES Microneedling Lawsuit?
  25. Why did the FDA warn about RF microneedling?
  26. Can AGNES microneedling cause facial fat loss?
  27. Is AGNES RF microneedling FDA cleared?
  28. Can I file an AGNES Microneedling Lawsuit?
  29. What is the deadline for filing an AGNES Microneedling Lawsuit?
  30. Is there an AGNES Microneedling Lawsuit settlement?
  31. References

On October 15, 2025, the U.S. Food and Drug Administration (FDA) issued a safety communication concerning serious injuries reported with certain uses of radiofrequency microneedling devices. A September 2026 medical study subsequently examined adverse-event reports involving the broader device category. Neither source establishes that AGNES devices are defective or subject to a recall.

Patients who experienced substantial injuries following AGNES treatment may have potential medical malpractice or product-liability claims. Eligibility depends on the circumstances of treatment, evidence of negligence or a product defect, medical causation, damages, and applicable filing deadlines.

Quick Facts

  • Devices: AGNES RF and AGNES Ultra radiofrequency electrosurgical systems manufactured by AGNES Medical Co., Ltd.
  • Safety warning: The FDA issued an industry-wide RF microneedling safety communication on October 15, 2025.
  • Potential injuries: Reported RF microneedling complications include burns, scarring, fat loss, disfigurement, and nerve damage.
  • Litigation status: The reviewed sources do not establish an AGNES-specific mass tort, personal-injury judgment, or nationwide settlement.

Latest News

November 2026

A November 20, 2026 review confirmed a study published in the September 2026 issue of Dermatologic Surgery examining adverse events associated with radiofrequency microneedling devices. Researchers analyzed FDA MAUDE reports from 2020 through 2025 and identified 86 medical-device reports containing 145 adverse events [1].

Fat loss, scarring, and post-inflammatory erythema were among the most frequently reported complications. The figures concern multiple RF microneedling products and do not represent confirmed AGNES-specific injury totals.

The study analyzed reports submitted to a medical-device surveillance database. Because the number of procedures performed was unavailable, the findings cannot establish a complication rate or compare the safety of individual manufacturers.

The review also confirmed the FDA’s October 15, 2025 safety communication addressing complications involving certain RF microneedling procedures. The agency identified burns, scarring, fat loss, disfigurement, nerve damage, and injuries requiring corrective treatment [2].

These findings support concern about potential treatment-related injuries. Neither the study nor the FDA communication establishes that AGNES Medical manufactured a defective device or that a specific patient experienced malpractice.

Targeted public litigation searches conducted during the November review did not identify an independently verifiable AGNES-specific personal-injury judgment or settlement. The searches were not a comprehensive review of federal and state court dockets.

September 2026

The September 2026 Dermatologic Surgery study examined safety reports involving commercially available RF microneedling systems. Researchers reviewed complications reported between 2020 and 2025.

The study’s 86 reports and 145 adverse events provide evidence of reported complications across the treatment category. They should not be interpreted as 145 confirmed injuries involving AGNES.

October 2025

On October 15, 2025, the FDA issued a safety communication about serious complications reported with certain dermatologic and aesthetic uses of RF microneedling devices.

The agency warned that some patients required surgical repair or other medical interventions. It encouraged patients and healthcare professionals to report suspected complications.

September 2025

On September 3, 2025, the FDA issued a substantial-equivalence determination for AGNES Ultra under 510(k) submission K250217. The device is classified as an electrosurgical cutting and coagulation system [3].

The FDA’s clearance documents identify the intended use as electrocoagulation and hemostasis during dermatologic and general surgical procedures. Clearance should not be interpreted as authorization for every cosmetic treatment advertised by a provider.

October 2019

On October 24, 2019, the FDA issued a substantial-equivalence determination for the original AGNES electrosurgical system under submission K192728 [4].

AGNES Medical’s published clinical FAQ identifies important treatment precautions. It warns that needle insertions placed too closely together can cause excessive heating and severe burns, and that microneedles are intended for single use [5].

The manufacturer’s guidance identifies recognized procedural hazards. It does not establish negligence or device malfunction in an individual patient’s treatment.

Event Month/Year Type Status Source Notes
RF microneedling adverse-event study September 2026 Medical research Published [1] Industry-wide adverse events examined
FDA RF microneedling warning October 2025 Safety communication Issued [2] Serious treatment complications identified
AGNES Ultra clearance September 2025 FDA 510(k) Cleared [3] K250217 substantial-equivalence decision
Original AGNES clearance October 2019 FDA 510(k) Cleared [4] K192728 substantial-equivalence decision

What Is AGNES RF Microneedling?

AGNES RF is a medical device that delivers radiofrequency energy through specialized needles inserted into the skin. The energy produces localized heating of targeted tissue.

Practitioners offer AGNES procedures for acne-related concerns, facial contouring, under-eye areas, and other aesthetic applications. Different needle configurations allow treatment at different anatomical locations and depths.

The regulatory status of a particular procedure depends on the device, its cleared indications, and how it is being used.

What’s the Problem With AGNES Microneedling?

RF microneedling intentionally heats tissue, creating a risk of unintended thermal injury. Excessive energy, inappropriate needle depth, closely spaced insertions, or inadequate patient selection may contribute to complications.

AGNES Medical warns that insufficient spacing between needle insertions can concentrate heat and cause severe burns. It also cautions against reusing needles because damaged insulation may increase injury risks.

These recognized hazards do not establish that every AGNES treatment is unsafe or that a particular injury resulted from defective equipment.

What Injuries Can RF Microneedling Cause?

The FDA’s October 2025 safety communication identifies serious complications associated with certain RF microneedling procedures.

  • Thermal burns and blistering
  • Scarring or persistent skin changes
  • Unintended facial fat loss
  • Skin depressions or contour irregularities
  • Discoloration or post-inflammatory pigmentation changes
  • Nerve injury or altered sensation
  • Disfigurement requiring corrective procedures
  • Persistent pain or other complications

Temporary swelling, redness, or discomfort may also occur after treatment. Persistent or worsening symptoms should be evaluated by a qualified healthcare professional.

Can AGNES Microneedling Cause Facial Fat Loss?

Radiofrequency energy can affect tissue beneath the skin, and unintended fat loss is among the complications identified in the FDA’s broader warning.

Some AGNES procedures intentionally target fatty tissue, making the treatment area and depth particularly relevant. Whether a particular patient experienced unintended fat loss requires medical evaluation and treatment-specific evidence.

Can AGNES Microneedling Cause Permanent Scarring?

Excessive thermal energy may damage skin and underlying tissue, potentially producing scars or lasting pigmentation changes.

AGNES Medical specifically warns that closely spaced needle insertions can increase accumulated heat and cause severe burns. Establishing permanent injury or negligent treatment requires examination of the patient’s medical records and clinical course.

Is AGNES Microneedling FDA Approved?

The FDA has granted 510(k) clearances for AGNES electrosurgical systems, including the original AGNES device and AGNES Ultra.

A 510(k) clearance is a substantial-equivalence determination, not the same regulatory pathway as FDA premarket approval. The documented indications concern electrocoagulation and hemostasis in dermatologic and general surgical procedures.

AGNES Medical’s FAQ acknowledges that aesthetic uses of its original RF system in the United States may be off-label. Patients should ask providers whether their particular procedure falls within the device’s cleared indications.

Is There an AGNES RF Microneedling Recall?

The FDA’s October 2025 action was a safety communication covering RF microneedling devices generally, not a recall of AGNES equipment.

The specific regulatory records examined for this article did not establish an AGNES recall connected to the injuries discussed. That limited finding does not guarantee that no separate corrective action exists or will occur.

Could an AGNES Microneedling Injury Lead to a Lawsuit?

Patients may have potential legal claims when treatment-related injuries result from legally actionable negligence or a defective medical device.

Medical malpractice allegations may involve improper treatment settings, failure to follow accepted clinical practices, inadequate informed consent, or deficient aftercare.

Product-liability claims require separate evidence supporting a defect, inadequate warning, or other legally recognized theory against a manufacturer or distributor.

Who Could Be Liable for an AGNES Treatment Injury?

Potentially responsible parties may include the treating clinician, clinic operator, supervising medical professional, or medical device manufacturer.

Liability depends on the cause of the injury, applicable professional duties, product condition, and evidence of causation. A poor cosmetic result alone does not establish negligence or a product defect.

Who May Be Affected by AGNES Microneedling Complications?

Potentially affected patients include individuals who underwent AGNES RF or AGNES Ultra treatment and subsequently experienced significant burns, scarring, unintended fat loss, nerve symptoms, or disfigurement.

Patients requiring corrective surgery, dermatology treatment, or other medical intervention may have questions about potential compensation. Eligibility requires individualized legal and medical evaluation.

Do I Qualify for an AGNES Microneedling Lawsuit?

The following questions may help determine whether a claim warrants evaluation:

  • Did you undergo treatment using an AGNES RF or AGNES Ultra device?
  • Did you develop substantial burns, scarring, facial fat loss, nerve damage, or another documented injury?
  • Were treatment risks, alternatives, and potential outcomes adequately explained before the procedure?
  • Do you have treatment records, before-and-after photographs, medical evaluations, or corrective treatment documentation?

Answering yes does not guarantee eligibility or compensation. An attorney can evaluate medical causation, informed consent, potential negligence, product defects, damages, and applicable filing deadlines.

What Evidence Is Important in an AGNES Microneedling Case?

Relevant documentation may include:

  • Clinic and practitioner information
  • Device model and treatment dates
  • Consent forms and advertising materials
  • Treatment settings and procedural records
  • Before-and-after photographs
  • Dermatology or plastic surgery evaluations
  • Corrective treatment and expense records
  • Communications with the treatment provider

These materials can help distinguish an expected complication from negligent treatment, device malfunction, or an unrelated medical condition.

How Can Patients Report RF Microneedling Injuries?

The FDA encourages patients and healthcare professionals to report suspected device-related complications through its MedWatch reporting program. Additional information about microneedling devices and their regulatory status is available through the FDA [6].

Submitting a report may help regulators monitor safety but does not independently establish malpractice or product liability.

What Compensation May Be Available?

Potential damages in a qualifying civil claim may include medical expenses, corrective procedures, lost income, pain and suffering, and other legally recognized losses.

Recovery depends on liability, medical causation, documented injuries, and applicable state law.

Compensation amounts vary by case. Past results do not guarantee future outcomes.

Speak With an AGNES Microneedling Lawyer

If you experienced substantial burns, scarring, facial fat loss, or another injury following AGNES microneedling, an attorney can review your treatment and medical documentation. A confidential case review can help determine whether the evidence supports a potential medical malpractice or product-liability claim.

How Does an AGNES Microneedling Lawsuit Work?

  1. Free case review. An attorney evaluates the treatment, injuries, and available legal theories.
  2. Investigation. Medical records, treatment settings, device information, and expert opinions may be examined.
  3. Filing. A qualifying claim may be filed against legally responsible parties.
  4. Discovery/negotiation. The parties exchange evidence, evaluate liability, and may discuss settlement.
  5. Resolution. The claim may conclude through settlement, dismissal, court ruling, or trial.

Frequently Asked Questions

What is the AGNES Microneedling Lawsuit?

The AGNES Microneedling Lawsuit refers to potential injury claims involving AGNES RF or AGNES Ultra treatments. The reviewed records do not establish an AGNES-specific mass tort, and any individual claim requires evidence of legally actionable conduct or a defective product.

Why did the FDA warn about RF microneedling?

The FDA received reports of burns, scarring, fat loss, disfigurement, nerve damage, and injuries requiring medical intervention. Its October 2025 communication addresses certain uses of RF microneedling devices generally and is not an AGNES-specific recall.

Can AGNES microneedling cause facial fat loss?

Unintended fat loss is a potential complication identified in the FDA’s broader RF microneedling safety warning. Determining whether AGNES caused a specific patient’s facial changes requires treatment records, clinical evaluation, and consideration of alternative explanations.

Is AGNES RF microneedling FDA cleared?

Yes, the FDA issued 510(k) clearances for the original AGNES device and AGNES Ultra under K192728 and K250217. These clearances concern specified electrosurgical indications and do not establish authorization for every cosmetic procedure offered by practitioners.

Can I file an AGNES Microneedling Lawsuit?

Patients with documented injuries may have potential claims involving negligent treatment, inadequate informed consent, or a defective device. Eligibility depends on evidence of causation, legally responsible parties, damages, and applicable filing deadlines.

What is the deadline for filing an AGNES Microneedling Lawsuit?

Filing deadlines depend on state law, the type of claim, and when the injury occurred or was discovered. Medical malpractice claims may have different deadlines and procedural requirements from product-liability actions, making an individualized legal review important.

Is there an AGNES Microneedling Lawsuit settlement?

The reviewed regulatory sources and targeted public litigation searches did not establish an AGNES-specific nationwide personal-injury settlement. Those searches do not exclude individual lawsuits, sealed proceedings, or private settlements that are not publicly indexed.

References

  1. PubMed
  2. U.S. Food and Drug Administration: Potential risks certain uses radiofrequency rf microneedling fda safety…
  3. FDA database
  4. FDA database
  5. lat.agnesmedical.com
  6. U.S. Food and Drug Administration